Obsidian Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates
Presented positive updated efficacy and pooled safety data on amsoki-cel in advanced melanoma at the
Presented positive updated efficacy and pooled safety data on amsoki-cel in advanced melanoma at the